These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1713421)

  • 21. Glomerular effects of cholera toxin in isolated perfused rat kidney: a potential role for platelet activating factor.
    Monteiro HS; Lima AA; Fonteles MC
    Pharmacol Toxicol; 1999 Sep; 85(3):105-10. PubMed ID: 10522748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritis.
    Bertani T; Livio M; Macconi D; Morigi M; Bisogno G; Patrono C; Remuzzi G
    Kidney Int; 1987 Jun; 31(6):1248-56. PubMed ID: 3039232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
    Doebber TW; Wu MS; Biftu T
    J Immunol; 1986 Jun; 136(12):4659-68. PubMed ID: 3011900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Charge selectivity in kidney ultrafiltration is associated with glomerular uptake of transport probes.
    Tay M; Comper WD; Singh AK
    Am J Physiol; 1991 Apr; 260(4 Pt 2):F549-54. PubMed ID: 1707241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Permselectivity of the glomerular capillary wall to macromolecules. II. Experimental studies in rats using neutral dextran.
    Chang RL; Ueki IF; Troy JL; Deen WM; Robertson CR; Brenner BM
    Biophys J; 1975 Sep; 15(9):887-906. PubMed ID: 1182263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of indomethacin on glomerular permselectivity and hemodynamics in nephrotoxic serum nephritis.
    Neugarten J; Kozin A; Cook K
    Kidney Int; 1989 Jul; 36(1):51-6. PubMed ID: 2478751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats.
    Gómez-Chiarri M; Ortíz A; Lerma JL; López-Armada MJ; Mampaso F; González E; Egido J
    Lab Invest; 1994 Apr; 70(4):449-59. PubMed ID: 8176885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-activating factor mediates monocyte chemoattractant protein-1 expression in glomerular immune injury.
    Jocks T; Freudenberg J; Zahner G; Stahl RA
    Nephrol Dial Transplant; 1998 Jan; 13(1):37-43. PubMed ID: 9481713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biosynthesis of platelet-activating factor. VI. Precursor of platelet-activating factor and acetyltransferase activity in isolated rat kidney cells.
    Pirotzky E; Ninio E; Bidault J; Pfister A; Benveniste J
    Lab Invest; 1984 Nov; 51(5):567-72. PubMed ID: 6492758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet activating factor biosynthesis and degradation in rat glomeruli.
    Zanglis A; Lianos EA
    J Lab Clin Med; 1987 Sep; 110(3):330-7. PubMed ID: 3611955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced glomerular permeability to macromolecules in the Nagase analbuminemic rat.
    Fujihara CK; Arcos-Fajardo M; Brandão De Almeida Prado E; José Brandão De Almeida Prado M; Sesso A; Zatz R
    Am J Physiol Renal Physiol; 2002 Jan; 282(1):F45-50. PubMed ID: 11739111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MK-591 acutely restores glomerular size selectivity and reduces proteinuria in human glomerulonephritis.
    Guasch A; Zayas CF; Badr KF
    Kidney Int; 1999 Jul; 56(1):261-7. PubMed ID: 10411701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: a study in early passive Heymann nephritis.
    Yoshioka T; Rennke HG; Salant DJ; Deen WM; Ichikawa I
    Circ Res; 1987 Oct; 61(4):531-8. PubMed ID: 2443267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-type calcium channel blockers modulate the microvascular hyperpermeability induced by platelet-activating factor in vivo.
    Oshiro H; Kobayashi I; Kim D; Takenaka H; Hobson RW; Durán WN
    J Vasc Surg; 1995 Dec; 22(6):732-9; discussion 739-41. PubMed ID: 8523608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PAF potentiates protamine-induced lung edema: role of pulmonary venoconstriction.
    Chen CR; Voelkel NF; Chang SW
    J Appl Physiol (1985); 1990 Mar; 68(3):1059-68. PubMed ID: 2341334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
    Handa RK; Strandhoy JW; Handa SE
    Kidney Blood Press Res; 2003; 26(3):165-75. PubMed ID: 12886044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glomerular responses to platelet-activating factor in the rat: role of thromboxane A2.
    Badr KF; DeBoer DK; Takahashi K; Harris RC; Fogo A; Jacobson HR
    Am J Physiol; 1989 Jan; 256(1 Pt 2):F35-43. PubMed ID: 2912165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-activating factor-induced increases in glucose kinetics.
    Lang CH; Dobrescu C; Hargrove DM; Bagby GJ; Spitzer JJ
    Am J Physiol; 1988 Feb; 254(2 Pt 1):E193-200. PubMed ID: 3348371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The parietal sheet of Bowman's capsule of rat renal glomerulus: a target of endothelin and PAF.
    Marchetti J; Meneton P; Lebrun F; Bloch-Faure M; Rajerison RM
    Am J Physiol; 1995 Jun; 268(6 Pt 2):F1053-61. PubMed ID: 7611446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary excretion of platelet-activating factor in human and experimental nephrosis.
    Bustos C; González E; González-Cuadrado S; Ortiz A; Muley R; de Nicolás R; Plaza JJ; Egido J
    Nephrol Dial Transplant; 1996 Feb; 11(2):282-6. PubMed ID: 8671780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.